FY2027 ICD-10-CM reference
C49: Malignant neoplasm of other connective and soft tissue
By the HCC Buddy Coding Team
The official ICD-10-CM descriptor is Malignant neoplasm of other connective and soft tissue. The FY2027 annual edition starts October 1, 2026. Check the edition that applies to the encounter or inpatient discharge, including any April update.
Nonbillable heading. Verified against the official FY2027 order file.
Oct to Dec 2026, PY2027
CMS-HCC V28
Not applicableCMS-HCC V24
Not applicableESRD
Not applicableRxHCC
Not applicablePACE (CMS-HCC V22 component)
Not applicablePACE ESRD (ESRD V21 component)
Not applicablePACE RxHCC (2018/2019 component)
Not applicableJan to Sep 2027, PY2028
CMS-HCC V28
Not applicableCMS-HCC V24
Not applicableESRD
Not applicableRxHCC
Not applicablePACE (CMS-HCC V22 component)
Not applicablePACE ESRD (ESRD V21 component)
Not applicablePACE RxHCC component
Not applicableOct to Dec 2026, BY2026
HHS-HCC
Not applicableJan to Sep 2027, BY2027
HHS-HCC
Not applicableMore specific FY2027 codes
- C49.0: Malignant neoplasm of connective and soft tissue of head, face and neckBillable code
- C49.1: Malignant neoplasm of connective and soft tissue of upper limb, including shoulderNonbillable heading
- C49.2: Malignant neoplasm of connective and soft tissue of lower limb, including hipNonbillable heading
- C49.3: Malignant neoplasm of connective and soft tissue of thoraxBillable code
- C49.4: Malignant neoplasm of connective and soft tissue of abdomenBillable code
- C49.5: Malignant neoplasm of connective and soft tissue of pelvisBillable code
- C49.6: Malignant neoplasm of connective and soft tissue of trunk, unspecifiedBillable code
- C49.8: Malignant neoplasm of overlapping sites of connective and soft tissueBillable code
- C49.9: Malignant neoplasm of connective and soft tissue, unspecifiedBillable code
- C49.A: Gastrointestinal stromal tumorNonbillable heading
FY2027 Tabular instructions
Instructions below include applicable chapter, section and parent-code notes. Each note identifies where it appears in the official source.
Instructional note
Functional activity
Source: C00-D49 (chapter, inherited).
Instructional note
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
Source: C00-D49 (chapter, inherited).
Instructional note
Morphology [Histology]
Source: C00-D49 (chapter, inherited).
Instructional note
Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
Source: C00-D49 (chapter, inherited).
Instructional note
Primary malignant neoplasms overlapping site boundaries
Source: C00-D49 (chapter, inherited).
Instructional note
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
Source: C00-D49 (chapter, inherited).
Instructional note
Malignant neoplasm of ectopic tissue
Source: C00-D49 (chapter, inherited).
Instructional note
Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Source: C00-D49 (chapter, inherited).
Includes
malignant neoplasm of blood vessel
Source: C49 (category, direct).
Includes
malignant neoplasm of bursa
Source: C49 (category, direct).
Includes
malignant neoplasm of cartilage
Source: C49 (category, direct).
Includes
malignant neoplasm of fascia
Source: C49 (category, direct).
Includes
malignant neoplasm of fat
Source: C49 (category, direct).
Includes
malignant neoplasm of ligament, except uterine
Source: C49 (category, direct).
Includes
malignant neoplasm of lymphatic vessel
Source: C49 (category, direct).
Includes
malignant neoplasm of muscle
Source: C49 (category, direct).
Includes
malignant neoplasm of synovia
Source: C49 (category, direct).
Includes
malignant neoplasm of tendon (sheath)
Source: C49 (category, direct).
Excludes1
malignant neoplasm of cartilage (of):
Source: C49 (category, direct).
Excludes1
articular (C40-C41)
Source: C49 (category, direct).
Excludes1
larynx (C32.3)
Source: C49 (category, direct).
Excludes1
nose (C30.0)
Source: C49 (category, direct).
Excludes1
malignant neoplasm of connective tissue of breast (C50.-)
Source: C49 (category, direct).
Excludes2
Kaposi's sarcoma of soft tissue (C46.1)
Source: C49 (category, direct).
Excludes2
malignant neoplasm of heart (C38.0)
Source: C49 (category, direct).
Excludes2
malignant neoplasm of peripheral nerves and autonomic nervous system (C47.-)
Source: C49 (category, direct).
Excludes2
malignant neoplasm of peritoneum (C48.2)
Source: C49 (category, direct).
Excludes2
malignant neoplasm of retroperitoneum (C48.0)
Source: C49 (category, direct).
Excludes2
malignant neoplasm of uterine ligament (C57.3)
Source: C49 (category, direct).
Excludes2
mesothelioma (C45.-)
Source: C49 (category, direct).
Compare the FY2027 additions, removals and billable-status changes
What does C49 mean in FY2027?
The official ICD-10-CM descriptor is Malignant neoplasm of other connective and soft tissue. The FY2027 annual edition starts October 1, 2026. Check the edition that applies to the encounter or inpatient discharge, including any April update.
Is C49 billable in FY2027?
The FY2027 order file marks C49 as a nonbillable heading. Select a complete billable child code.
Does C49 map to an HCC?
Risk-model mapping is not applicable to this nonbillable heading. Check a complete billable child code.
Source: CMS FY2027 ICD-10-CM order file. Payment model: CMS CY 2027 Rate Announcement. Read the FY2027 Official Guidelines.
Review the FY2026 April edition
